Try it
Pharmacology · Anticancer drugs
Sample itemA patient receiving high-dose methotrexate for osteosarcoma develops severe mucositis and myelosuppression. Which agent is used to rescue normal cells, and how does it work?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. Leucovorin, by bypassing dihydrofolate reductase inhibition
Methotrexate inhibits dihydrofolate reductase and depletes reduced folates. Leucovorin (folinic acid) is already in the reduced form and replenishes the folate pool in normal cells without requiring the enzyme. It is given with high-dose therapy and in overdose.
Option by option
A. Dexrazoxane, by chelating iron in myocardium
Dexrazoxane reduces anthracycline cardiotoxicity.
B. Mesna, by binding toxic metabolites in the urine
Mesna protects the bladder from acrolein produced by cyclophosphamide and ifosfamide.
C. Leucovorin, by bypassing dihydrofolate reductase inhibition (correct)
Correct. Leucovorin is a reduced folate that does not need dihydrofolate reductase.
D. Amifostine, by scavenging free radicals in the kidney
Amifostine reduces cisplatin nephrotoxicity and radiation xerostomia.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.